Nattokinase Evidence: Blood Pressure, Clots and Safety

Quick Answer: What Does the Nattokinase Evidence Support?

Pure City Research describes nattokinase as an enzyme obtained from natto, a fermented soybean food. The source separates laboratory fibrin-degradation activity from outcomes after a person swallows a supplement. That distinction is central: activity measured outside the body does not by itself show that oral nattokinase reaches or treats a clot inside the body.

What Do Fibrinolytic Units Show?

Pure City Research explains that nattokinase potency is expressed in fibrinolytic units, or FU. FU describe activity in a laboratory assay. They do not establish absorption, prove a clinical effect, or show that a swallowed product dissolves a clot in a person.

This page does not convert FU into a universal milligram amount, dosage, meal schedule, clock time or coating requirement. Research protocols and commercial forms are context—not personal instructions and not proof about a pending Pure City formulation.

Pure City Research Evidence Verdicts

The grades below are the conclusions reported by Pure City Research. This Shop summary does not independently re-grade the underlying studies.

Why Laboratory Activity Is Not a Human Treatment Effect

Pure City Research says the widely repeated clot and microclot narrative depends on laboratory work in which nattokinase is applied to fibrin-containing samples outside the body. The source says that kind of result cannot show, by itself, that an oral capsule survives digestion, is absorbed in a clinically meaningful form, reaches a clot, or changes a health outcome.

The same boundary applies to Long COVID. According to Pure City Research, no published human randomized trial has established that nattokinase reduces microclots or improves Long-COVID symptoms. A plausible laboratory mechanism is not a proven treatment.

Safety and Medicine-Combination Concerns

Vitamin K2 Is Product-Specific

Pure City Research says vitamin K2 content can vary among nattokinase products and can matter for warfarin. Do not infer the vitamin K2 status of a particular product from natto origin, from another product, or from this article. The final label and verified product records must answer that product-specific question.

Not an FDA-Approved Clot Treatment

Pure City Research says nattokinase is sold in the United States as a dietary supplement, not an FDA-approved drug for treating, dissolving or preventing blood clots.

Questions People Ask

Can nattokinase dissolve clots or microclots in my body?

Pure City Research says human clinical-trial evidence has not established that it does. The source grades this claim Insufficient.

Does nattokinase help with Long COVID?

Pure City Research reports no published human randomized trial for Long-COVID symptoms or microclot reduction and grades the claim Insufficient.

Does nattokinase lower blood pressure?

Pure City Research grades the evidence Moderate and describes the average effect as modest. That is not proof that a supplement is appropriate for an individual, not a reason to change blood-pressure care, and not evidence that a Pure City product produces the same result.

Can I take nattokinase with warfarin, aspirin or another blood-thinning medicine?

Not on the basis of this page. Pure City Research flags serious medicine-combination concerns. Ask the clinician managing the medicine before considering nattokinase, and do not change prescribed treatment or monitoring yourself.

Does this page prove that Pure City's product is enteric-coated or vitamin-K2-free?

No. The ingredient research does not establish the final formulation, coating, vitamin K2 result, label directions or finished-lot result for a Pure City product. Use the current product page, final label and verified lot records for those product-specific facts.

Editorial, Product and Funding Boundary